Mark A Varney Insider Trading $RSPI RespireRx Pharmaceuticals Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark A Varney.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark A Varney. Mark A Varney is Chief Scientific Officer in RespireRx Pharmaceuticals Inc. ($RSPI) and President and CEO in RespireRx Pharmaceuticals Inc. ($RSPI).
Mark A Varney in RespireRx Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark A Varney: President and CEO, Chief Scientific Officer
Holdings: 30,000 shares
Current Value: $117,000
Latest Transaction: Aug 24 2009
$RSPI Market Capitalization: $7.87M
$RSPI Previous Close: $3.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark A Varney in RespireRx Pharmaceuticals Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24 2009 | RSPI | RespireRx Pharmace ... | Varney Mark A | President and CEO | Option Exercise | A | 0.20 | 588,000 | 117,600 | 588,000 | |
| Aug 13 2008 | RSPI | RespireRx Pharmace ... | Varney Mark A | President and CEO | Option Exercise | A | 0.97 | 200,000 | 194,000 | 200,000 | |
| Jan 22 2008 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
| Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.48 | 12,385 | 5,945 | 30,000 | 17.6 K to 30 K (+70.31 %) |
| Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.48 | 1,500 | 720 | 17,615 | 16.1 K to 17.6 K (+9.31 %) |
| Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.49 | 5,000 | 2,450 | 16,115 | 11.1 K to 16.1 K (+44.98 %) |
| Nov 23 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.46 | 7,115 | 3,273 | 11,115 | 4 K to 11.1 K (+177.88 %) |
| Nov 23 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.45 | 4,000 | 1,800 | 4,000 | 0 to 4 K |
| Dec 20 2006 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 1.30 | 250,000 | 325,000 | 250,000 | |
| Jan 31 2006 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 2.95 | 750,000 | 2,212,500 | 750,000 |
Page: 1